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ABSTRACT  
A continuously seeded L-glutamic acid cooling crystallization process, in a continuous 
oscillatory baffled crystallizer, was designed and operated to deliver control over polymorphic 
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form. Different feed solution concentrations and seed loadings of ȕ L-glutamic acid crystals were 
examined. Steady-state operation, based on particle size distribution and polymorphic form, was 
demonstrated consistently after two residence times. Where bulk supersaturation remained in the 
range 2 - 3, polymorphic phase purity of the thermodynamically stable ȕ polymorph was retained. 
However, when bulk supersaturation exceeded this range to values of 3 - 8, primary nucleation of 
the metastable ɲ polymorph was observed and product crystals were a mixed phase. In the absence 
of seeding the system could not be operated without significant encrustation to the vessel surface 
thus leading to loss of control, whereas a continuously seeded approach allowed robust processing 
for at least 10 h.  
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INTRODUCTION  
Limitations in fully characterizing the physical transformations involved in crystallization often 
relate to the challenges in measuring the formation of crystal nuclei and their subsequent growth. 
In addition, many organic materials are polymorphic1,2 and adopt chemically identical solid forms 
possessing different physiochemical properties including solubility and stability, as well as particle 
properties, such as particle size distribution (PSD) and morphology, potentially influencing bio-
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availability and downstream processability. Thus the control of polymorph formation, subsequent 
growth and possible transformations, is a fundamental requirement for development of robust 
pharmaceutical crystallization processes.3,4 
The pharmaceutical industry has traditionally relied upon batch methods for crystallization and 
the production of active pharmaceutical ingredients (APIs). However, drivers to produce higher 
quality materials with less batch-to-batch variability and more efficient equipment are increasingly 
becoming a priority.5 As a consequence, the continuous manufacturing of pharmaceuticals has 
received much interest across industry, academia and regulatory communities.6-11 
Oscillatory flow systems have drawn recent attention within the continuous manufacturing and 
crystallization community.12 A continuous oscillatory baffled crystallizer (COBC) is a type of 
plug-flow reactor (PFR) which allows continuous cooling crystallization, moving solutions and/or 
suspensions through a series of periodically spaced orifice baffled tubes. The application of 
oscillatory flow results in the formation of eddies between the baffles13 providing efficient mixing 
regions and near-plug flow operation.12,14,15 The improved uniformity of the internal environment 
with respect to distributions of shear rates, temperature gradients and mass transfer,16,17 combined 
with the decoupling of mixing and net flow,18 provides the potential for effective operation and 
scaling of laboratory pharmaceutical crystallization processes to industrial-sized processes.19 Of 
particular attraction, the ability to extend the mean residence time, under plug-flow conditions, at 
a similar mixing intensity,20 is advantageous to slow processes such as crystallization where longer 
residence times are needed for the induction of nucleation and the subsequent growth of crystals, 
in addition to a uniform mixing environment facilitating uniform crystal growth.  
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Continuous oscillatory flow may be described using three dimensionless numbers; ܴ݁R, the 
oscillatory Reynolds number, ܵݐ, the Strouhal number and ܴ݁, the net flow Reynolds number.21 ܴ݁R describes the intensity of oscillatory mixing applied within the tube. ܵݐ is the ratio of the tube 
diameter to the oscillation amplitude and a measure of the eddy propagation inside each inter-
baffle zone. The definition of amplitude is the distance between the minimum and maximum 
displacement of fluid within the tube as a function of the applied oscillation. In the literature, half 
this distance is usually reported i.e. center-to-peak as opposed to peak-to-peak and given the 
symbol ߯௢. ܴ݁ is a descriptor based on the net flow. These are governed by the following 
equations: 
ܴ݁R ൌ ଶగᐦఞ೚ ఘௗఓ  (1) ܵݐ ൌ  ௗସగఞ೚  (2) ܴ݁ൌ ఘ௨ௗఓ   (3) 
 ݀ = internal tube diameter (m), ߯௢ = center-to-SHDN DPSOLWXGH P¦  IUHTXHQF\ +] ȡ = 
density (kgm-3), ȝ = fluid viscosity (kgm-1s-1), and ݑ = mean velocity (ms-1). Flow should be fully 
reversing (to maximize the mixing effect) and to achieve this ܴ݁R should be > ܴ݁. A velocity 
ratio,߰, was proposed to relate the oscillatory velocity to the net flow velocity15 and is described 
by: ߰ൌ ோ௘ோ௘  (4) 
Recommendations for oscillatory flow14,15,22-25 include operating with ܴ݁R  100, ܵݐ  0.5, ܴ݁ 
 50, and velocity ratios between 2 and 10.  
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There have been limited studies of crystallization within continuous oscillatory flow; to date the 
majority of oscillatory baffled flow crystallizations have been completed in batch mode. Reports 
using a batch oscillatory baffled crystallizer (OBC) include investigations with paracetamol,16,26,27 
sodium chlorate28,29 and adipic acid.30 Batch OBCs have been designed to allow investigation of 
similar type mixing environments prior to continuous experimentation whilst minimizing 
consumption of material.12 Only two papers9,19 report a basic methodology towards continuous 
oscillatory crystallization where batch OBC crystallizations were carried out before continuous 
trials were completed. Specifically, L-glutamic acid (LGA) has been successfully crystallized in a 
batch OBC.31-33 However, neither the continuous crystallization of LGA operated in a COBC nor 
a suitable seeding strategy have been reported.  
LGA can be classified as a drug-like material.34 It is present in many food products and plays an 
important role in many neurodegenerative diseases.35,36 LGA has two known polymorphs with 
distinct characteristic morphologies. They are monotropically related with ɲ-LGA having the 
higher solubility across the temperature range of interest in this work.37 Therefore LGA presents 
itself as an ideal candidate for investigating control of polymorphism. The metastable ɲ form 
exhibits prismatic crystal morphology, whilst the thermodynamically stable ȕ form adopts a plate 
or needle-like shape.  
Extensive studies around the batch crystallization of LGA cover many crystallization aspects 
including kinetic studies on nucleation and growth rates,38-41 polymorph control,42-44  
supersaturation (SS, defined in the Materials and Methods Section) control,45-47 purity,48 
population balance modeling (PBM),49,50 effects of additives51-53 and solution mediated 
polymorphic transformation.37,54,55 The numerous batch investigations of LGA typically focus on 
small scale stirred tank crystallizer (STC) platforms (<1 L) and span a range of crystallization 
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types including reactive, cooling and anti-solvent. Scale dependence has been reported56,57 where 
comparisons were made between operating in an STC at a scale of ca. 0.5 L up to 20 L, illustrating 
the need to understand the impact of vessel hydrodynamics at various scales on the crystallization 
process. Furthermore process analytical technology (PAT) coupled with a control system has been 
utilized to develop an industrial pilot scale (250 L) batch crystallization process for the production 
of ȕ-LGA.58 
However, there are only few reports illustrating continuous crystallization of LGA. Grier et al. 
patented a process generating the metastable ɲ form using a continuous stirred tank reactor in 
1968.59 Here a feed stock was supplied as the aqueous LGA growth solution to a 4 L STC 
containing ɲ-LGA seeds and continuously pumping slurry to a second STC for further 
crystallization before a latter isolation stage. The process covered a residence time (RT) of ca. 2 
h, and temperature ranges from 0 ± 25 °C. Roelands et al. described a continuous reactive 
crystallization of LGA using sodium glutamate and dilute sulfuric acid.60 The two solutions were 
continuously mixed in a Y-mixer, in order to create high SSs ranging from 4 ± 22 and complete 
mixing, before transfer to a collection vessel where the solution experienced post-mixing or 
quiescent conditions. When no post-mixing was applied the resulting polymorphic form was 
consistently the stable ȕ form. However, post-mixing treatments to the solutions favored the 
production of ɲ-LGA. A continuous anti-solvent crystallization process producing the stable ȕ 
form was reported by Myerson et al.61 In this study a 300 mL, 2.4 m, PFR with Kenics® type static 
mixers was utilized. Acetone was added as an anti-solvent to the aqueous LGA solution at multiple 
positions along the reactor length and the effects of anti-solvent addition on the resulting chord 
length distributions were discussed. The RT for this study was ca. 2 min, experiments were 
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conducted at 25 °C and the process was operated for 7 residence times producing ȕ-LGA with no 
observations of the metastable ɲ form reported.  
More recently a mixed suspension mixed product removal (MSMPR) set-up was used to study 
the aqueous continuous cooling crystallization of LGA.62 A 300 mL STC was operated with 
periodic addition and withdrawal of growth solution and slurry product respectively, and operation 
time scales were reported to be up to 6 d. Here, both seeded and unseeded methodologies were 
studied. During unseeded crystallization both polymorphs were produced in pure phase, ɲ-LGA 
using a crystallization procedure at 25 °C and ȕ-LGA at 45 °C. This work illustrated challenges in 
producing the stable ȕ form during continuous operation. Due to the higher growth rate of ɲ-LGA 
when compared to the ȕ form, it was concluded if ɲ nucleates in the presence of ȕ, a polymorphic 
switch occurs during continuous operation, similar to conclusions drawn from the aforementioned 
continuous reactive crystallization of LGA.60 This study62 also suggests that seeded approaches at 
steady state continuous operation may not be sufficient to control polymorphism within an 
MSMPR. 
Although there have been several crystallization studies in oscillatory flow platforms and 
numerous investigations on the crystallization behavior of LGA, the continuous crystallization of 
pharmaceutically relevant materials is not well documented. In addition to this, the application of 
continuous oscillatory flow for pharmaceutical crystallization is substantially limited and seeding 
strategies in a COBC have not been previously reported. Moreover, control of polymorphic forms 
of LGA in a COBC has not been successfully achieved. Herein, we report the development of a 
continuously seeded, cooling crystallization process resulting in polymorphic phase pure LGA in 
a COBC. 
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MATERIALS AND METHODS  
Materials. ȕ-LGA SXULW\&$6-86-0, FCC) FRQWDLQLQJ 0.1 % of the ɲ form was 
purchased from Sigma Aldrich, Germany. De-ionized water was sourced on-site from a Thermo 
Scientific Barnstead RO water purification unit. Experiments were performed in an air conditioned 
laboratory at 20 ± 2 °C.  
Equipment. Seeded crystallizations of LGA were performed in a 15 mm internal diameter 
COBC mounted horizontally, the set-up consisted of 32 jacked glass tubes (straights) and 8 non-
jacked glass bends. The geometry of the COBC is shown in Figure 1. Cooling water was circulated 
through the jackets in a counter current manner by heater/chillers (HCs) (Lauda Eco RE 630S). 
Peristaltic pumps (Watson-Marlow 520S) supplied the COBC with growth solution and seed 
suspension stored in two independently heated feed tanks. The temperature of the second COBC 
glass straight (S2) and the seed suspension were controlled by the same HC to maintain the solution 
at a SS of approximately 1. Thermocouples, 24 in total, were used to record the cooling profile of 
thirteen temperature zones, each zone controlled by 1 HC, zones are shown in color in Figure 2. 
Fluid oscillation was provided by a fluid filled bellows unit controlled by custom electronics 
(housed in a control box). Before tube lines were changed over to supply the feedstock and seeds, 
both the COBC and the bellows unit were flushed with water using peristaltic pumps. During 
crystallization, slurries were collected at the outlet. The main feed growth solution was prepared 
at two concentrations, and the seed suspension prepared at two seed loadings. The total length and 
volume of the system were 25 m and 5.1 L respectively, however as the seeding port was located 
between straights 2 and 3, 30 straights and 8 bends were used for growth. The operating conditions 
are summarized in Table 1.   
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Figure 1. COBC geometry and set-up for seeded experiments. Photograph of a single glass 
COBC straight (left), inset shows a magnified image of a single inter-baffle zone, with dimensions 
indicated and a photograph of the COBC set-up (right) used for seeded COBC experiments.  
 
 
Figure 2. COBC set-up for seeded crystallizations. Schematic of the seeded COBC 
crystallization platform. Thermocouple positions are shown, and the 13 temperature zones are 
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indicated by colors (zone 1 S1, zone 2 S2, zone 3 S3±S6, zone 4 S7±S10, zone 5 S11-S13, zone 6 
S14±S16, zone 7 S17±S18, zone 8 S19±S20, zone 9 S21±S22, zone 10 S23±S26, zone 11 S27±
S28, zone 12 S29±S30 and zone 13 S31±S32). 
 
Table 1: COBC seeded crystallization operating parameters 
Frequency 
(Hz) 
Amplitude 
(mm) 
Main flow 
(g/min) 
Seed flow 
(g/min) 
Ren Reo Ȍ St 
1 30 30 20 70 1400 20 0.008 
 
Analytics. Solid materials were characterized off-line via x-ray powder diffraction (XRPD). 
XRPD fingerprinting was performed on ca. 50 mg of sample placed in a 28 well plate, supported 
by KDSWRQILOPȝPWKLFNQHVV'DWDZDVFROOHFWHGRQDBruker AXS D8 Advance transmission 
GLIIUDFWRPHWHU HTXLSSHG ZLWK șș JHRPHWU\ SULPDU\ PRQRFKURPDWLF UDGLDWLRQ &X .Į1 Ȝ = 
1.54056 Å), a Braun 1D position sensitive detector and an automated multi-position x-y sample 
stage. Data was collected from 4-șZLWKDșVWHSsize and 1 s step-1 count time. XRPD 
powder patterns were compared with known standards using Bruker-AXE software Eva 2 or a 
Pawley-type fit made to the data with the known unit cell parameters63,64 using Dash 3.3.2. 
Optical images were acquired using a Motic B1 series microscope equipped with 4x, 10x, 40x 
and 100x magnification objective lenses. Images were visualized using Motic Images 2.0 software. 
PSDs were obtained by laser diffraction measurements, using a Mastersizer 2000 (Malvern 
Instruments). Slurries were dispersed in a saturated solution (LGA and water) using a Hydro 
2000SM dispersion unit. Slurry was added to the dispersion until the laser obscuration reached 6 
%. Five measurements were averaged for each sample.  
Supersaturation (SS).  
Throughout this manuscript, SS values are expressed in terms of the SS ratio (ܵ) defined by:  
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ܵ ൌ  ܥܥכ (5)  = solution concentration and כ = equilibrium solution concentration (at a constant temperature 
and pressure). 
Sample preparation. For LGA samples, solid slurries where removed, immediately filtered 
(Millipore 0.45 ȝm papers) and washed before drying in an oven at 40 °C until constant mass. 
Seed preparation. Seeds were prepared using a turbulent jet reverse anti-solvent process, (see 
Electronic Supporting Information, ESI). Using this method, ȕ-LGA seeds with a mean size ca. 10 
ȝm were produced. 
 
Figure 3. Seed Crystals used for the crystallization of LGA in a COBC. SEM image (left), 
optical microscope image (middle) and PSD (right) of LGA seed crystals. The seed obtained from 
the continuous anti-solvent process display a flake like morphology.  
 
Operating conditions. Four continuously seeded COBC experiments were carried out (Table 
2) comprising a basic design with a high and low feed solution concentration and a high and low 
seed mass loading. This design space was used to assess control over crystal growth and 
polymorphic form during continuous crystallization. COBC operating conditions were selected to 
ensure a sufficient RT was available for particle growth (ca. 80 minutes) alongside the operation 
within a near plug-flow domain. It should be noted that we have performed a full residence time 
distribution (RTD) study on the COBC configuration described herein highlighting axial 
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dispersion values below those stated in literature defining plug-flow operation65 which we intend 
to publish elsewhere. 
Table 2: Experimental conditions used for seeded COBC experiments. 
Seed mass 
loading  
Feed solution concentration 
(g/kg(solution)) 
High 
40g/kg 
Low 
18g/kg 
High 
0.4 (g/kg) 
Expt. 1 Expt. 2 
Low 
0.1 (g/kg) 
Expt. 3  Expt. 4 
 
 
RESULTS AND DISCUSSION  
 
Continuous unseeded experiments. A number of unseeded crystallizations were carried out 
using a similar set-up to Figure 2 but without using a seeding suspension vessel (see ESI). 
Crystallizations were completed over a range of concentrations, cooling profiles, oscillatory 
conditions and flow rates (20 - 45 g/kg, 0.3 - 3 °C/min, 1 - 2 Hz, 20 - 30 mm, 20 - 120 g/min, 
respectively). Under all conditions investigated where primary nucleation was induced, 
encrustation of the glass surface was dominant and subsequent crystal growth on the glass walls 
led to numerous detrimental effects including loss of control of PSD, blockages and ultimately 
process shut down.  
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Figure 4: Encrustation and blockages during unseeded crystallization in a COBC. 
Photograph A (left) shows COBC glass straights during operation: a clear solution prior to 
nucleation (7), severe encrustation (11) and encrusted walls with a dense suspension of crystalline 
material flowing through (14). Photographs (B and C, right) show dismantled equipment after an 
unseeded COBC run. Polyether ether ketone (PEEK) collars (B) with a complete blockage (left) 
in comparison to a clean collar (right) and a partial blockage and restriction of a COBC bend (C).  
Encrustation during unseeded crystallizations prevented a comprehensive study of nucleation 
kinetics and process development of LGA in the COBC. In general, encrustation presents a severe 
risk in continuous crystallization processes and if not properly managed prevents operation for 
extended periods. Uncontrolled accumulation of material on vessel walls can disrupt heat transfer, 
alter SS, lead to increases in back pressure, vary oscillatory conditions, affect particle size, lead to 
non-steady state operation and in many cases cause process failure. These issues highlight the need 
to ensure adequate control of SS throughout the crystallization process in order to ensure sufficient 
crystal growth, minimize undesired nucleation and prevent attachment of crystals at the vessel 
surface.  
Encrustation of crystallization vessel surfaces during the crystallization of LGA has not been 
reported extensively. In the aforementioned MSMPR study,62 the unseeded continuous 
crystallization of LGA could be carried out for up to 45 hours (45 residence times) without reports 
of encrustation.  However, some reports on STC investigations make reference to difficulties in 
obtaining reliable information from PAT due to fouling of probes during unseeded 
crystallizations56 as well as reference to impeller shafts accumulating LGA encrusted material.57 
The COBC has a surface area per unit volume over one order of magnitude higher than an 
equivalent volume STC (see ESI). Therefore a higher extent of local SS close to the surface during 
cooling operation can potentially increase the likelihood of encrustation, particularly over 
extended periods of operation. Encrustation challenges have been described in the literature66,67 
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and mitigation and control strategies include seeding,68 ultrasound69 and dynamic modelling within 
flow.70 
In over 30 continuous unseeded crystallization experiments, the COBC exclusively produced 
the metastable ɲ phase. In a small number of these unseeded studies trace amounts of the ȕ form 
were observed.  This is in contrast to reported batch OBC experiments under similar operating 
conditions31-33 where no surface encrustation was reported and polymorph selectivity could be 
achieved. For the work presented here, the approach used eliminates the need for primary 
nucleation under high SS within the COBC through the use of continuous seeding using seeds 
produced from a continuous anti-solvent process (details in ESI). 
Continuous seeded crystallization experiments. Seeded crystallization involving controlled 
growth of particles can be operated at relatively low SS. This should therefore reduce the potential 
for encrustation within the COBC as the need to drive the system to high SS to induce primary 
nucleation is eliminated and indeed this is a common strategy used to control crystallization 
kinetics as well as polymorphic form.43,71-73 The seeding strategy provides a predetermined number 
of seeds of the desired form and size into the supersaturated primary feed solution for controlled 
growth. The seeding approach was developed from a series of small scale studies in which seed 
loadings and temperatures profiles were investigated.71,74 The selected conditions which gave 
acceptable control over growth rate and polymorphic form are shown in Table 2. Four seeded 
continuous crystallization experiments were carried out to investigate the product particle 
properties (size and polymorphic form) and operating conditions for continuously seeded ȕ-LGA 
crystallization (Table 2). Figure 5 shows the measured temperature profiles used during each of 
the continuously seeded continuous crystallization experiments.  
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Figure 5 Cooling profiles for seeded LGA COBC experiments. Plot showing measured 
temperatures during seeded COBC crystallisations. Temperature zones (Figure 2) are indicated 
e.g. zone 3 (Z3), zone 4 (Z4) etc. 
 
Crystal growth and polymorphism.  Over the four COBC experiments completed (Table 2) 
crystal growth and polymorphic purity were assessed. Figure 6 shows the final resulting product 
PSDs and Table 3 shows the resulting mean particle sizes. When a seeding methodology is used 
to control crystal growth without the formation of new nuclei, the conservation of seed number 
can be presumed with the assumption that no agglomeration occurs. In this scenario the mass 
balance can be expressed as follows:75 
ௐೞା௒೟ௐೞ ൌ  ቀ௅ೞ೛௅ೞ ቁଷ (6) 
௦ܹ= mass of seeds, ௧ܻ = mass of dissolved solute forming crystals,  ܮ௦௣ = product crystal size, ܮ௦ = size of seed crystals. Thus, as expected from the mass balance, lower feed solution 
concentrations (experiments 2 and 4) yielded smaller mean crystal size (ca. 90 ȝm and ca. 70 ȝm) 
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than higher feed solution concentrations (1 and 3; mean crystal sizes ca. 240 ȝm and ca. 320 ȝm 
were observed).  Similarly, the effect of seed loading follows the expectation where a high seed 
loading (experiment 1) leads to a smaller size, as compared to a low seed loading (experiment 3) 
leading to a larger size. However the seed loading effect with a low feed solution concentration 
deviates from expectation with the larger seed loading (experiment 2) producing a mean size of 
ca. 20 ȝm larger than the lower seed loading (experiment 4). It is worth keeping in mind however 
that the nature of Mastersizer measurements and the fairly high extent of agglomeration in the 
system will have had an impact on these values. Notably, the combination of lower seed loading 
with high concentration led to the occurrence of encrustation in the system accompanied by 
primary nucleation of ɲ-LGA. This is as a consequence of loss of control over SS during the 
process (experiment 3). It is also worth noting that all PSDs show the presence of fines which 
suggests a small amount of primary/secondary nucleation and/or some crystal breakage during 
operation.  
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Figure 6: PSDs from seeded LGA crystallizations in the COBC. Plot showing the PSDs from 
experiments 1, 2, 3 and 4 (Table 2). The mean particle sizes were 240, 90, 320 and 70 ȝm 
respectively. 
 
Table 3: Mean particle size from seeded LGA experiments in the COBC.  
Seed mass 
loading  
Feed solution concentration  
High Low 
High 
 
Expt. 1 
240 ȝm 
Expt. 2 
90 ȝm 
Low 
 
Expt. 3 
320 ȝm  
Expt. 4 
70 ȝm 
 
Product crystals collected from all experiments were agglomerates. Representative images of 
the product crystals from the seeded experiments are shown in Figure 7. The elongated plate 
morphology of the crystals within the agglomerate can be observed. Due to this agglomeration, 
the overall particle growth mechanism did not follow that of individual crystals therefore this 
posed challenges in drawing firm conclusions around the relationships between the impact of 
seeded loading and solution concentrations on crystal growth.   
 
Figure 7 Images of crystal product from seeded crystallizations. Optical (left) and SEM (right) 
images of agglomerated product crystals (experiment 2, Table 2) obtained from a seeded COBC 
cooling crystallization process.  
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The methodology here uses a simple mass balance based approach to deliver an initial design 
space. Current practice of crystallization process design and control include utilization of PBM to 
describe the relationship between process kinetics and product size distribution from first 
principles in addition to the application of model based feedback control strategies from PAT.3,76-
79 Further work to develop a PFR PBM which can also account for agglomeration is ongoing in-
house in addition to work developing a heat transfer model within the COBC to enable more 
accurate temperature control. Such capabilities will enable further process optimization based on 
first principles mechanistic understanding, however the current study highlights the ability to 
develop continuous crystallization processes capable of delivering consistent particle size whist 
avoiding encrustation and exploiting standard crystallization process design approaches.  
Over each of the four continuously seeded experiments encrustation was not observed with the 
exception of experiment 3. Experiment 3 (high main feed concentration, low seed loading) was 
anticipated to generate the highest SS within the system. This fouled experiment was shut down 
after only 3 RTs due to substantial observed encrustation on the glass walls and the potential 
hazards associated with blockages alongside the danger of damaging equipment.  
On examination of the product material using XRPD, experiment 3 alone was shown to contain 
the metastable ɲ form. Figure 8 shows an overlay of product material from seeded experiments. 
Powder patterns of the pure ɲ and ȕ (simulated from single crystal data) are also shown. These 
results illustrate that primary nucleation of the metastable form of LGA had occurred at some point 
within the COBC. Experiment 3 indicates exceeding SSs where growth and secondary nucleation 
of ȕ-LGA is favorable, and moving into a domain where primary nucleation of ɲ-LGA is favorable, 
thus loss of process control over physical phase purity.  
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Figure 8: XRPD data from seeded continuous LGA crystallizations. Figure showing an overlay 
of product material from seeded experiments (Table 2), reference powder patterns of the pure 
alpha and beta (simulated from single crystal data)63,64 are also shown.  
 
SS profiling. To measure SS values along the COBC, customized sampling bends (see ESI) 
were designed and positioned at bends 1, 2, 4, 6 and 7 for experiment 3. Slurry samples were 
extracted and rapidly filtered. Subsequently, solutions were evaporated and SSs were calculated 
after weighing the resulting crystal product using a mass balance. Figure 9 shows the calculated 
SS values from the mass balance of the extracted samples. Here a constant increase in SS along 
the COBC length can be observed during experiment 3. Final SS values from experiments 1, 2 and 
4 (ranging from ca. 2 ± 3) are shown in addition to the starting SS at the seeding point.  
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Figure 9: SS profile along the COBC. The graph illustrates the measured SS from manual 
samples illustrating a constant increase in bulk SS over the continuous crystallization process 
during experiment 3 (Table 2). Final SS values from experiments 1, 2 and 4 (ranging from ca. 2 ± 
3) are shown in addition to the starting SS at the seeding point.  
 
The final SS values have been overlaid on the LGA phase diagram for reference in Figure 10. 
Using the smallest metastable boundary, proposed elsewhere for spontaneous nucleation of LGA 
from an aqueous system in batch oscillatory baffled flow conditions,31 it can be illustrated that 
when the bulk SS remains below this boundary the result is thermodynamically stable ȕ form. 
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Figure 10: LGA crystallization diagram. Graph showing the temperature dependent solubility 
of LGA measured gravimetrically.80 Final measured SS values from continuous seeded 
experiments (open symbols) and initial seeding point concentrations (closed symbols) are shown 
in addition to the narrowest metastable boundary reported for spontaneous nucleation of LGA 
within oscillatory flow.31 
 
Given the metastable zone width (MSZW) is a kinetic parameter dependent on many 
experimental considerations including concentration, agitation, temperature and volume, the 
boundary used in Figure 10 only serves as a guide. In reality the MSZW for continuous 
experiments should be assessed under the same operations conditions used within the seeded 
experiments. The results presented here indicate a MSZW somewhere between SS values of 3 - 5 
and between these values primary nucleation of the metastable form, in the presence of ȕ crystals, 
is favorable. Further work is needed to define the maximum SS limit where the system can be 
operated controlling phase purity. However, this work begins to define successful regions for 
continuous operation.   
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Steady state operation. During continuous processing, there is a period where parameters 
change before the system stabilizes. For a given process to fulfil its intended purpose the defined 
critical quality attributes (CQAs), e.g. desired polymorphic form, purity or PSD, should remain 
within the specified critical limits after this stabilization period and thus, steady state is reached. 
To maximize process efficiency, the time period between start-up and consistent production of 
material within specifications should ideally be minimized. 
Efficient achievement of steady state may be assessed by investigation of CQAs with respect to 
time. Figure 11 shows representative examples of the change in PSD for each product sample, 
collected over several successive RTs, during unseeded and seeded continuous crystallizations. On 
comparison, it can be observed that a constant product PSD output is not obtained with unseeded 
crystallizations by the second RT and the product PSD moves from a uni-modal to a bi-modal 
distribution. However during seeded crystallizations, after the second RT the PSD remains 
consistent. The deviation from steady state in unseeded crystallizations can be explained as a 
consequence of uncontrolled crystallization and encrustation during operation. The unseeded 
product PSDs suggest secondary nucleation events, creating a shift in the PSD with respect to time. 
Furthermore, detachment of encrusted solids from the vessel walls during operation was observed 
and this results in an additional contribution to non-steady state product size distributions. Over a 
10 h run time of seeded COBC crystallizations no visible signs of encrustation (during operation 
and cleaning) were observed when the SS levels were maintained in the range 2 - 3 and PSDs 
suggest controlled growth of the seed particles, with minimal fines, resulting in a consistent 
product PSD output. This steady state illustration of PSD with seeded experiments also highlights 
a robust process for PSD control of LGA.  
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Figure 11: Evolution of PSDs during continuous crystallization. Graphs showing an overlay of 
6 product sample PSDs collected from an unseeded (left) and continuously seeded (right) LGA 
COBC process.  
 
Steady state after the second RT was obtained routinely when encrustation did not occur in the 
COBC. The previously mentioned unseeded PFR study61 was reported to reach steady state, with 
respect to the stable ȕ form, within the longer time of 4 - 10 RTs and operated for 14 m, however 
this study relied on spontaneous nucleation and thus it would be anticipated that seeding would 
facilitate achieving steady state more quickly. The unseeded MSMPR investigations62 show 
selectivity over polymorphic form at various temperatures, the metastable form being isolated at 
lower temperature of 25 °C after 2 RTs and the stable ȕ form at the high temperature of 45 °C. 
This is in contrast to the COBC unseeded experiments, where the metastable ɲ form was isolated 
exclusively regardless of temperature. On comparison with other continuous platforms illustrating 
continuous production of LGA, the COBC, when seeded, requires a smaller number of RTs to 
reach steady state production of the stable ȕ-polymorph. It should be mentioned however that it is 
difficult to compare these platforms directly. 
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Conclusions. Throughout all unseeded continuous experiments, significant encrustation was 
observed and this could not be eliminated despite a multitude of changes to the operation and 
process conditions. For continuous LGA cooling crystallization it is advisable to avoid primary 
nucleation in the system although further work is needed around mitigating and possible control 
of encrustation. High SS coupled with a large surface area creates the potential of competitive 
deposition of material on the reactor walls. It is therefore recommended that for extended operation 
COBCs are well suited to lower SS operation with separation of high SS nucleation and low SS 
growth conditions although this is clearly system dependent.  
When a seeded approach was taken, PSD and polymorphic steady state was reached by the 
second RT and operation for 8 RTs (10 h) was illustrated without encrustation or blockage of the 
system. Operation for longer periods of time was beyond the scope of this study. When the bulk 
solution SS remained within the range 2 - 3, encrustation was avoided. Seeding with 10 ȝm crystals 
resulted in final particles with mean sizes ranging from ca. 70 ± 320 ȝm within a RT of ca. 80 
minutes allowing for the tailoring of crystal particle size. The need for continuous seeding also 
highlights the requirement for developing efficient strategies for the production of seeds and 
ideally an in-situ approach would be advantageous, eliminating the need for isolation and 
subsequent re-suspension.  
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NOMENCLATURE 
݀ Internal tube diameter, m ߩ Density (kgm-3) ᐦ frequency (Hz) 
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߯௢ centre-to-peak amplitude (m) ߤ viscosity (kgm-1s-1) ݑ mean velocity  (ms-1) ܴ݁ net flow Reynolds number ܴ݁R oscillatory Reynolds number ܵݐ Strouhal number ߰ velocity ratio ௦ܹ mass of seeds ௧ܻ mass of dissolved solute forming crystals ܮ௦௣ product crystal size ܮ௦ size of seed crystals ܵ supersaturation ratio ܥ solution concentration ܥכ equilibrium solution concentration 
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